The personalisation of healthcare is one of the biggest global drivers of innovation in medical technology and pharmaceuticals today. Advances in genomics have created opportunities to deliver patient specific information to tailor treatments to the individual in a way never before possible. The new ‘omics revolution is set to empower clinicians and patients to make informed decisions on care pathways – but how far have we progressed in terms of delivering on the promises of precise and personalised medicine?
Date: Monday 7th November, 2016 Time: 7:30am for a networking breakfast followed by presentations until 9.00am Venue: The Royal Society of Victoria, 8 La Trobe St, Melbourne VIC 3000
All proceeds from this event go directly to fund Innovation Week 2016
$50 for Members and Non-Members
About Innovation Week
Innovation Week is an annual celebration of innovation in science, technology, engineering, mathematics and medicine (STEMM) in Australia led by the Australian Science and Innovation Forum (ASIF) in partnership with the Australian Academy of Technological Sciences and Engineering (ATSE).
The goal of the week is to foster an innovation culture that values basic research, features the translation of discoveries, celebrates successful teams as well as emerging entrepreneurs and start-ups.
Associate Professor Ajeet Singh MD, CEO and Founder, CNSDose
Video message from the Hon. Greg Hunt, Minister for Industry, innovation and Science
Full refund given up to 7 days prior to the event
No refunds within 7 days of the event
Professor Kathryn North AM
Professor North is trained as a paediatric physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate from the University of Sydney for research into Neurogenetics. Her previous positions include the Douglas Burrows Professor of Paediatrics, Faculty of Medicine, University of Sydney from 2004 to 2012 and Head of the Institute for Neuroscience and Muscle Research 2008 to 2012.
Her laboratory research interests focus on the molecular basis of inherited muscle disorders, as well as genes which influence normal skeletal muscle function and elite athletic performance. Her clinical research focuses on clinical trials of therapies for muscular dystrophy as well as the development of interventions for children with learning disabilities.
Professor North has received a number of awards for her research including the GSK Australia Award for Research Excellence in 2011, the Ramaciotti Medal for Excellence in Biomedical Research in 2012 and the Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research in 2012. In the same year, Professor North was appointed Chair of the NHMRC Research Committee and Member of NHMRC Council.
In 2013, Professor North was appointed Vice Chair of the Steering Committee and Co-Chair of the Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH). GA4GH is an international consortium of more than 200 institutions across 30 countries, focusing on the global sharing of genomic and clinical data and its application to improvement in patient diagnosis and treatment.
A/Prof Ajeet Singh MD
Dr Ajeet Singh is an award-winning Australian Psychiatrist and Pharmacogeneticist with an international standing in the field and the CEO of CNSDose. A Melbourne based start-up, CNSDose is a cloud-based medication guidance system that enables doctors and patients to reduce trial and error in the prescribing of anti-depressants